International Clinical Trial: A Study to Compare the Safety and Effectiveness of Unani Formulation Habb Mujarrab with Celecoxib for relief of pain and swelling in adults with Rheumatoid Arthritis

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116833) titled 'A Study to Compare the Safety and Effectiveness of Unani Formulation Habb Mujarrab with Celecoxib for relief of pain and swelling in adults with Rheumatoid Arthritis' on Sept. 1.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Permuted block randomization, fixed Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Outcome Assessor Blinded

Primary Sponsor: National Research Institute of Unani Medicine for Skin Disorders

Condition: Health Condition 1: M069- Rheumatoi...